Literature DB >> 10529188

Lysine 22 in UDP-N-acetylglucosamine enolpyruvyl transferase from Enterobacter cloacae is crucial for enzymatic activity and the formation of covalent adducts with the substrate phosphoenolpyruvate and the antibiotic fosfomycin.

A K Samland1, N Amrhein, P Macheroux.   

Abstract

UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) catalyzes the first committed step in the biosynthesis of the bacterial cell wall component peptidoglycan. The enzyme is the target of the antibiotic fosfomycin. A lysine residue (K22), strictly conserved in MurAs and the structurally and mechanistically related 5-enolpyruvylshikimate 3-phosphate synthases (EPSPS), is located near the active center of the enzyme. This residue is thought to be involved directly in the binding of the substrate phosphoenolpyruvate (PEP) and also to participate in the conformational change leading to the formation of the catalytically competent enzyme complex. Using site-directed mutagenesis, we have replaced this lysine with arginine (K22R), valine (K22V), and glutamate (K22E). These mutant proteins were expressed, purified, and characterized in comparison to wild-type MurA and a previously described inactive C115S mutant protein. It was found that all three K22 mutant proteins had less than 0.5% of the wild-type activity. Using isothermal titration calorimetry, it could be shown that the binding parameters for the UDP-sugar nucleotide substrate are not affected by the mutations, except for the K22E mutant protein. Similarly, binding of PEP was found to be unaffected in the K22 mutant proteins as demonstrated by tryptophan fluorescence quench titrations. On the other hand, the level of formation of a covalent adduct with either PEP or fosfomycin with the thiol group of cysteine 115 was diminished. The propensity to form an adduct with PEP decreased in the following order: wild type >> K22R > K22V > K22E. A comparable effect was found on the formation of the inhibitory covalent adduct of MurA and the antibiotic fosfomycin. These results are discussed in terms of an involvement of lysine 22 in a conformational change of MurA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529188     DOI: 10.1021/bi991041e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

Review 1.  The structural biology of enzymes involved in natural product glycosylation.

Authors:  Shanteri Singh; George N Phillips; Jon S Thorson
Journal:  Nat Prod Rep       Date:  2012-06-12       Impact factor: 13.423

2.  Study of intra-inter species protein-protein interactions for potential drug targets identification and subsequent drug design for Escherichia coli O104:H4 C277-11.

Authors:  Shakhinur Islam Mondal; Zabed Mahmud; Montasir Elahi; Arzuba Akter; Nurnabi Azad Jewel; Md Muzahidul Islam; Sabiha Ferdous; Taisei Kikuchi
Journal:  In Silico Pharmacol       Date:  2017-04-11

3.  Functional consequence of covalent reaction of phosphoenolpyruvate with UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA).

Authors:  Jin-Yi Zhu; Yan Yang; Huijong Han; Stephane Betzi; Sanne H Olesen; Frank Marsilio; Ernst Schönbrunn
Journal:  J Biol Chem       Date:  2012-02-29       Impact factor: 5.157

4.  Structural and functional characterization of NikO, an enolpyruvyl transferase essential in nikkomycin biosynthesis.

Authors:  Gustav Oberdorfer; Alexandra Binter; Cristian Ginj; Peter Macheroux; Karl Gruber
Journal:  J Biol Chem       Date:  2012-07-18       Impact factor: 5.157

5.  Comparison of the essential cellular functions of the two murA genes of Bacillus anthracis.

Authors:  G C Kedar; Vickie Brown-Driver; Daniel R Reyes; Mark T Hilgers; Mark A Stidham; Karen Joy Shaw; John Finn; Robert J Haselbeck
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

6.  Cloning, expression and characterization of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Wolbachia endosymbiont of human lymphatic filarial parasite Brugia malayi.

Authors:  Mohd Shahab; Meenakshi Verma; Manisha Pathak; Kalyan Mitra; Shailja Misra-Bhattacharya
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.